Clinical guidelines for the use of prolonged-release buprenorphine (Buvidal®) in the treatment of opioid dependence [PDF] (Record no. 21034)

000 -LEADER
fixed length control field 00713nam a22002177a 4500
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 200504b xxu||||| |||| 00| 0 eng d
040 ## - CATALOGING SOURCE
Transcribing agency VAD
041 ## - LANGUAGE CODE
Language code of text/sound track or separate title Engels
110 ## - MAIN ENTRY--CORPORATE NAME
Corporate name or jurisdiction name as entry element SMMGP
245 ## - TITLE STATEMENT
Title Clinical guidelines for the use of prolonged-release buprenorphine (Buvidal®) in the treatment of opioid dependence [PDF]
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT)
Place of publication, distribution, etc Shrewsbury
Name of publisher, distributor, etc SMMGP
Date of publication, distribution, etc 2020
300 ## - PHYSICAL DESCRIPTION
Extent 54 p.
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element drugs
Topical term or geographic name as entry element injecterende druggebruikers
Topical term or geographic name as entry element hulpverlening
Topical term or geographic name as entry element buprenorfine
Topical term or geographic name as entry element richtlijnen
Topical term or geographic name as entry element behandelrichtlijnen
Topical term or geographic name as entry element Verenigd Koninkrijk
856 ## - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier http://www.google.com/search?q=Clinical-guidelines-for-the-use-of-prolonged-release-buprenorphine
Holdings
Withdrawn status Lost status Damaged status Not for loan Permanent Location Current Location Date acquired Date last seen Koha item type
        VAD VAD 2020-05-04 2020-05-04 E-bron